Use

Dimazole, an antifungal agent, was introduced in 1951 for the treatment of tinea infections. Although the major manufacturer subsequently discontinued marketing preparations in the United States, the US Food and Drug Administration formally withdrew marketing approval for such preparations in 1977 on the grounds of their association with severe neurotoxic reactions, their potential for misuse and the availability of safer alternative products. Topical preparations of dimazole remain available in some 40 countries.

dimazole manufacturers

• Diamthazole
• 
• US $1980.00-2500.00 / mg
• 2025-04-28
• CAS:95-27-2
• Min. Order:
• Purity:
• Supply Ability: 10g